Clinical Pharmacology Studies with Indobufen (K 3920): Inhibitor of Platelet Aggregation
- 6 May 1980
- journal article
- research article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 20 (5-6) , 316-325
- https://doi.org/10.1177/009127008002000502
Abstract
Click on the article title to read more.This publication has 13 references indexed in Scilit:
- PLATELET FACTOR 3 AVAILABILITY AND THE RELEASE REACTIONActa Medica Scandinavica, 2009
- Indobufen, a new inhibitor of platelet aggregation. Studies in guinea pigsPharmacological Research Communications, 1979
- Pharmacokinetic, bioavailability and pharmacodynamic study of indobufen (K 3920), an inhibitor of platelet aggregation, after a single dose in manEuropean Journal of Clinical Pharmacology, 1979
- Sulfinpyrazone in the Prevention of Cardiac Death after Myocardial InfarctionNew England Journal of Medicine, 1978
- Aspirin Prophylaxis of Venous Thromboembolism after Total Hip ReplacementNew England Journal of Medicine, 1977
- Acetylsalicylic acid, low dose heparin, and a combination of both substances in the prevention of postoperative thromboembolism. A double blind studyThrombosis Research, 1977
- Postoperative Thrombembolie-Prophylaxe mit AcetylsalicylsäureDeutsche Medizinische Wochenschrift (1946), 1974
- Reduction in Venous Thromboembolism by Agents Affecting Platelet FunctionNew England Journal of Medicine, 1971
- The aggregation of blood plateletsThe Journal of Physiology, 1963
- Morphology and Enumeration of Human Blood PlateletsJournal of Applied Physiology, 1950